Assisted Reproductive Technologies
Assisted Reproductive Technologies are all treatments which include the handling of eggs and sperm and/or embryos. Some examples of ART are in vitro fertilization (IVF), gamete intrafallopian transfer (GIFT), pronuclear stage tubal transfer (PROST), tubal embryo transfer (TET), and zygote intrafallopian transfer (ZIFT).
What's New at ASRM
- Fertility and Sterility On Air - Unplugged: July 2022
- ASRM COVID-19 Task Force Releases Update #9 to Recommendations
- Colorado court balances religious and secular beliefs in frozen embryo divorce dispute
- UPDATE No. 18 - COVID-19 Vaccination, Booster Shots and Reproductive Health Care
- The Supreme Court Overturns Right to Abortion, Raising Questions and Uncertainties for ART Patients and Providers
- Fertility and Sterility On Air – TOC: June 2022
- ASRM Today: QA Dashboard for SART CORS with Dr. Amy Sparks
- Fertility and Sterility On Air - Unplugged: June 2022
- ASRM Today: Factors affecting IVF success among underrepresented minorities with Dr. Jerrine Morris (Re-Broadcast)
- Fertility and Sterility On Air - TOC: February 2023
- ASRM COVID-19 Task Force Releases Update #10 to Recommendations
- ASRM Issues New Guidance on Fertility Care During COVID-19 Pandemic: Calls for Suspension of Most Treatments
- Office of Personnel Management Expands Fertility Coverage
- ASRM Applauds Introduction of the Right to Build Families Act
- Fertility and Sterility On Air– TOC: September 2022
- ASRM Today - Update #9 from the ASRM COVID-19 Task Force with Christos Coutifaris
- Fertility and Sterility On Air - TOC: April 2022
- Fertility and Sterility On Air– TOC: August 2022
- Fertility and Sterility On Air - TOC: March 2023
- More Than 73 Thousand Babies Born from Assisted Reproductive Technology Cycles Done in 2020
- Most patients resumed IVF treatment during the COVID-19 pandemic shut-down immediately when able
- FAQs for Patients Related to COVID-19
- Fertility and Sterility On Air– TOC: July 2022
- Update #1 Released to the ASRM Patient Management and Clinical Recommendations During The Coronavirus (COVID-19) Pandemic
Resources
- Infertility treatments, including IVF and similar procedures, account for approx 0.07 percent of U.S. health care costs
- One Million IVF Babies
- Challenges of parenting multiples 养育多胞胎的挑战
- What is ICSI 什么是卵胞浆内单精子注射
- Complicaciones de la gestacion multiple (Complications of multiple pregnancy)
- Derechos y responsabilidades en relación con la fertilidad (Fertility rights and responsibilities)
- Gestacion multiple y reduccion embrionaria (Multifetal pregnancy reduction)
- Los farmacos para la fertilidad y el risego de partos multiples (Fertility medications and the risk of multiple birth)
- Tratamiento de la pérdida recurrente de embarazos (Treatment of recurrent pregnancy loss)
- What is In Vitro Fertilization?
- The Goal Of Infertility Treatment
- Multiple Pregnancy Is Risky
- Acupuncture and infertility treatment 针灸与不孕不育的治疗
- IVF: What are the risks? 体外受精:风险有哪些?
- ¿Qué debo saber sobre el virus Zika y tratar de tener un bebé? (What do I need to know about Zika virus and having a baby?)
- Suplementos de progesterona durante los ciclos de fertilización in vitro (FIV) (Progesterone supplementation during IVF cycles)
- Is In Vitro Fertilization Expensive?
- Who Needs An Egg Donor? - a patient education micro-video
- Understanding the SART Clinic Report - a patient education micro-video
- Multiple Pregnancy and Multiple Births: Understanding the Risks for Mothers and Babies - a patient education micro-video
- Infertility Treatments - a patient education video
- Assisted hatching 辅助孵化
- Smoking and infertility 吸烟和不孕不育
- Why would I choose to have elective single-embryo transfer? 我为什么要接受选择性单胚胎移植
- ¿Qué es la maduración in vitro (MIV)? (What is IVM?)
- Cuidado reproductivo fronterizo (Cross-border reproductive care)
- Eclosión asistida (Assisted hatching)
- Embarazo y nacimientos múltiples: mellizos, trillizos, o mayor número de bebés (Multiple pregnancy and birth booklet)
- Evaluación del útero (Evaluation of the uterus)
- Síndrome de hiperestimulación ovárica-SHO (Ovarian hyperstimulation syndrome [OHSS])
- Transferencia electiva de un único embrión (Elective single embryo transfer)
- Assisted Hatching
- Connecticut
- Hawaii
- Louisiana
- Maryland
- Massachusetts
- Montana
- New Jersey
- New York
- Ohio
- Texas
- West Virginia
- Medications for inducing ovulation 排卵诱导药物
- Ovarian hyperstimulation syndrome (OHSS) 卵巢过度刺激综合征
Publications
- Updated terminology for gamete and embryo donors: directed (identified) to replace ‘‘known’’ and nonidentified to replace ‘‘anonymous’’: a committee opinion (2022)
- Disparities in access to effective treatment for infertility in the United States: an Ethics Committee opinion (2021)
- Ethics Webinar: Dilemmas in Embryo Disposition
- Best practices of ASRM and ESHRE: a journey through reproductive medicine (2012)
- Current recommendations for vaccines for female infertility patients: a committee opinion (2018)
- The International Glossary on Infertility and Fertility Care (2017)
- Defining embryo donation: an Ethics Committee opinion (2016)
- Fertility treatment when the prognosis is very poor or futile: an Ethics Committee opinion (2019)
- Reproductive and infertility care in times of public health crises: an Ethics Committee opinion (2022)
- Consideration of the gestational carrier: an Ethics Committee opinion (2023)
- Smoking and infertility: a committee opinion (2018)
- Ethics Webinar: Access to Infertility Care
- Child-rearing ability and the provision of fertility services (2017)
- Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion (2022)
- Informing offspring of their conception by gamete or embryo donation: an Ethics Committee opinion (2018)
- Posthumous retrieval and use of gametes or embryos (2018)
- A review of best practices of rapid-cooling vitrification for oocytes and embryos: a committee opinion (2021)
- ASRM standard embryo transfer protocol template: a committee opinion (2017)
- Clinical management of mosaic results from preimplantation genetic testing for aneuploidy (PGT-A) of blastocysts: a committee opinion (2020)
- Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline (2018)
- Evaluation and treatment of recurrent pregnancy loss: a committee opinion (2012)
- Fertility evaluation of infertile women: a committee opinion (2021)
- Minimum standards for practices offering assisted reproductive technologies: a committee opinion (2021)
- Role of assisted hatching in in vitro fertilization: a guideline (2022)
- Subclinical hypothyroidism in the infertile female population: a guideline (2015)
- Micro-presentation: Fertility Treatment When The Prognosis Is Very Poor Or Futile
- Disclosure of medical errors involving gametes and embryos: an Ethics Committee opinion (2016)
- Misconduct in third-party assisted reproduction: an Ethics Committee opinion (2018)
- Oocyte or embryo donation to women of advanced reproductive age: an Ethics Commitee opinion (2016)
- Transferring embryos with genetic anomalies detected in preimplantation testing: an Ethics Committee Opinion (2017)
- Micro-presentation: Fertility Preservation in Patients Undergoing Gonadotoxic Therapy or Gonadectomy
- Blastocyst culture and transfer in clinically assisted reproduction: a committee opinion (2018)
- Correct coding for laboratory procedures during assisted reproductive technology cycles (2016)
- Guidance for Providers Caring for Women and Men Of Reproductive Age with Possible Zika Virus Exposure (2019)
- Evidence-based treatments for couples with unexplained infertility: a guideline (2020)
- Fertility drugs and cancer: a guideline (2016)
- In vitro maturation: a committee opinion (2021)
- Obesity and reproduction: a committee opinion (2021)
- Multiple gestation associated with infertility therapy: a committee opinion (2022)
- Intracytoplasmic sperm injection (ICSI) for non–male factor indications: a committee opinion (2020)
- Performing the embryo transfer: a guideline (2017)
- Recommended practices for the management of embryology, andrology, and endocrinology laboratories: a committee opinion (2014)
- Development of an emergency plan for in vitro fertilization programs: a committee opinion (2021)